REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 120 filers reported holding REVOLUTION MEDICINES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,215 | -99.4% | 152,290 | +293.8% | 0.04% | +300.0% |
| Q3 2022 | $763,000 | +0.9% | 38,676 | -0.2% | 0.01% | +11.1% |
| Q2 2022 | $756,000 | +33.6% | 38,766 | +74.7% | 0.01% | +28.6% |
| Q1 2022 | $566,000 | +120.2% | 22,187 | +117.0% | 0.01% | +133.3% |
| Q4 2021 | $257,000 | -35.3% | 10,226 | +18.1% | 0.00% | -50.0% |
| Q1 2021 | $397,000 | -27.6% | 8,662 | -37.4% | 0.01% | +20.0% |
| Q4 2020 | $548,000 | – | 13,834 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,524,031 | $151,966,000 | 28.85% |
| Ponoi II Management, LLC | 685,011 | $18,845,000 | 27.92% |
| Ponoi Management, LLC | 685,011 | $18,845,000 | 16.73% |
| Column Group LLC | 3,347,245 | $92,083,000 | 10.48% |
| TRV GP IV, LLC | 1,419,900 | $39,061,000 | 8.86% |
| Cormorant Asset Management, LP | 3,144,700 | $86,511,000 | 3.52% |
| Boxer Capital, LLC | 3,484,264 | $95,852,000 | 3.35% |
| BVF INC/IL | 2,485,049 | $68,364,000 | 2.67% |
| Casdin Capital, LLC | 2,800,000 | $77,028,000 | 1.92% |
| COMMODORE CAPITAL LP | 226,228 | $6,224,000 | 1.64% |